Smartlens is an ophthalmic technology company specializing in developing innovative solutions for diagnosing and treating chronic eye diseases. With a strong focus on addressing unmet needs in ophthalmology, the company's pipeline includes cutting-edge technologies that will facilitate improved clinical decision-making while also paving the way for a new generation of therapies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/11/23 | $6,100,000 | Series A |
3E Bioventures Ambit Health Ventures  Boutique Venture Partners Graphene Ventures Plaisance Capital Management Sophia Innovation Capital Stanford University Wilson Sonsini Investments | undisclosed |
